Carrier screening is based on a simple biological premise. Many severe genetic disorders, including thalassemias, metabolic conditions, and neuromuscular diseases, follow an autosomal recessive inheritance pattern, meaning a child is affected only when both parents carry a pathogenic variant in the same gene. Carriers themselves are typically completely healthy, with no symptoms and often no family history, which is precisely why untargeted testing has historically missed so many at-risk couples. When both members of a couple are carriers of variants in the same gene, each pregnancy carries a 25 percent chance of being affected. Knowing this risk in advance opens a range of reproductive options, from preimplantation genetic testing during in vitro fertilization to prenatal diagnosis, informed family planning, and preparation for the medical care an affected child might need.

What distinguishes the Singapore program is its deliberate tailoring to Asian genetic diversity. Rather than adopting a panel built around variants common in European populations, the team designed a customized 112-gene panel targeting recessive diseases that are population-specific to the major ancestral groups represented in the country, including Chinese, Malay, Indian, and other Asian communities. This approach reflects a growing recognition in genomics that variant databases and screening panels calibrated on European data perform poorly elsewhere, both missing genuine carriers and generating confusing results from variants that behave differently across ancestries. Singapore, with its compact geography and well-characterized multiethnic population, provides an ideal setting to demonstrate how precision medicine can be adapted to Asian diversity rather than imported wholesale from Western frameworks.

The program operates nationwide, and its pilot phase began in September 2024. Participants receive culturally tailored online education about the screening program before providing samples, and results are returned with genetic counseling and a full discussion of reproductive options. The numbers reported so far illustrate both the appetite for such testing and the practical realities of implementation. Since the pilot began, 1,619 couples have registered interest in the program, and 60 percent of those deemed eligible went on to participate. Among the 550 couples who had received their results at the time of reporting, six couples, or 1.0 percent, were identified as being at increased risk of having a child affected by a recessive genetic condition. That figure, while small in absolute terms, represents couples who now have the knowledge to make fully informed reproductive decisions, something that would otherwise have remained invisible to them.

Beyond the laboratory and clinic, the research team invested heavily in understanding how the wider community views genetic screening, recognizing that a program’s success depends as much on social acceptance as on scientific accuracy. The researchers surveyed 1,002 community members, including both couples who had participated in the program and members of the general public. The results showed that interest in carrier screening was high, with 59 percent of respondents expressing interest across the cohort. However, the survey also revealed important fault lines: awareness of carrier screening, intent to participate, and understanding of the implications for reproductive options differed significantly by sociodemographic factors such as ancestry and religion. These findings underscore that a one-size-fits-all communication strategy would leave parts of the population behind, potentially exacerbating existing health inequities rather than reducing them.

Religious and cultural sensitivity emerged as a central theme of the implementation effort. The team engaged directly with religious leaders, whose support for the program was indicated through the engagement process, a step that reflects the realities of implementing reproductive genetics in a society where religious beliefs can shape attitudes toward prenatal testing and reproductive choice. By building these relationships before scaling up, the program aimed to ensure that its messaging and services would be culturally appropriate and that communities would not feel targeted or stigmatized by screening offers. This kind of groundwork is often overlooked in genomic medicine programs, which tend to emphasize technical validation over social license, but the Singapore experience suggests the two are inseparable.

The healthcare professional perspective revealed a different set of challenges. Among 113 healthcare professional respondents, there was broad acknowledgment that carrier screening will become routine in medical care, a consensus that mirrors international trends as sequencing costs fall and professional guidelines expand. Yet the same respondents reported limited confidence and limited resources for delivering this service. This gap between expected demand and workforce readiness is a familiar problem in genomics. Genetic counseling capacity is scarce in most countries, and frontline physicians in obstetrics, general practice, and family medicine often receive little training in interpreting carrier screening results or communicating residual risk. The Singapore findings suggest that any country contemplating population screening must budget as much for professional education and counseling infrastructure as for the genetic tests themselves.

The program sits within a broader national strategy. It forms part of Singapore’s National Precision Medicine initiative, a multi-phase government effort to build genomic infrastructure tailored to Asian populations, supported by the National Research Foundation and the Ministry of Health. Funding for the carrier screening program itself came through the Temasek Foundation and strategic academic funds, with the community questionnaire study supported by Singapore’s Social Science Research Council. This layered funding model, combining philanthropy, national research investment, and health system integration, may prove instructive for other countries weighing how to finance genomic screening programs that are expected to run for decades rather than years.

The technical architecture of the program also merits attention. The 112-gene panel was developed with contributions from the hospital’s DNA Diagnostic and Research Laboratory and the national diagnostics manufacturing hub, with a dedicated reporting system built at the National Heart Centre Singapore. Variant classification follows established frameworks from the American College of Medical Genetics and Genomics, and population frequency data drawn from resources such as the Genome Aggregation Database inform the interpretation of variants in the local context. Ethics approval was obtained from the SingHealth Centralised Institutional Review Board, and the program’s design incorporated input from clinical geneticists, genetic counselors, and genetics nurses who reviewed the educational content delivered to participants. The result is an end-to-end system in which education, testing, reporting, and counseling are integrated rather than bolted together.

The authors conclude that these early outcomes and community engagement findings are now guiding the expansion of population-based carrier screening in Singapore, but they are explicit that this expansion is contingent on addressing practical challenges through equitable outreach and professional training. The study’s significance extends well beyond the island nation. Most of the world’s population lives in Asia, yet genomic screening programs have been designed and validated overwhelmingly in Europe, North America, and Australia. Singapore’s experience demonstrates that population-specific panels, culturally grounded engagement, and honest assessment of healthcare workforce limitations can be combined into a workable national program. As other Asian countries develop their own precision medicine strategies, the Singapore model offers both a technical template and a cautionary lesson: the genetics may be the easy part, and the harder work lies in earning the trust of diverse communities and preparing clinicians to translate genomic knowledge into genuinely useful reproductive choices.

Subject of Research: Implementation of population-based reproductive carrier screening for diverse Asian populations in Singapore

Article Title: Implementing reproductive carrier screening to include diverse Asian populations: insights from Singapore

Article References: Bylstra, Y., Juann, M. Y., Teo, J. X., Goh, J., Choi, C., Chan, S., Song, C., Yin Goh, J. C., Siew Chai, N. B., Lieviant, J. A., Toh, H. J., Chan, S. H., Blythe, R., Menezes, M., Yang, C., Hodgson, J., Graves, N., Sng, J., Lim, W. W., … Jamuar, S. S. (2026). Implementing reproductive carrier screening to include diverse Asian populations: insights from Singapore. BMC Medicine. https://doi.org/10.1186/s12916-026-05286-w

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05286-w

Keywords: reproductive carrier screening, genetic testing, precision medicine, Singapore, Asian populations, autosomal recessive disease, genetic counseling, population screening, community engagement, healthcare professionals, gene panel, thalassemia

The research, led by a team at Peking University working with the Chinese National Twin Registry, took a two-pronged approach. On one side, the investigators analyzed twin data from 2,548 individuals, comparing identical twins, who share essentially all of their DNA, with fraternal twins, who share roughly half. On the other side, they mined GWAS summary statistics from more than 92,615 participants in Asian cohorts. By estimating heritability through both classical twin modeling and modern SNP-based methods, they could directly compare the two traditions and quantify exactly where the numbers diverge.

The traits under scrutiny were ten of the most clinically important cardiometabolic measures: body mass index (BMI), waist-to-hip ratio (WHR), hemoglobin A1c (HbA1c), fasting blood glucose (FBG), systolic and diastolic blood pressure (SBP and DBP), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Together, these markers capture the biological landscape of obesity, glucose metabolism, blood pressure regulation, and blood lipid profiles—the very factors that drive the world’s leading causes of death.

The headline result is striking. Twin-based analyses yielded moderate to high heritability estimates, ranging from 0.34 to 0.72 across the ten traits, meaning that between a third and nearly three-quarters of the variation in these measures could be attributed to genetic differences. GWAS-based estimates, by contrast, came in far lower, between 0.10 and 0.22. This confirms, in an Asian population, the same pattern long observed in European cohorts: twin studies see more heritability than GWAS can account for, leaving a substantial residue that must be explained by other mechanisms.

One leading candidate for the missing heritability has been non-additive genetic effects—particularly dominance effects, where the combined action of two alleles at a locus produces an effect that simple additive models cannot capture. To test this, the team built structural equation models that decompose trait variance into additive genetic, dominance genetic, shared environmental, and unique environmental components. The verdict was unambiguous: dominance genetic variance was statistically significant only for BMI, with an estimated dominance component of 0.42, and no evidence of non-additive effects appeared anywhere in the GWAS summary statistics. For most cardiometabolic traits, the dominant role of simple additive inheritance stands, and the missing heritability cannot be pinned on gene-gene interactions of this kind.

That leaves gene-environment interactions as a prime suspect, and here the study delivered some of its most intriguing findings. Using variance components models that allow genetic and environmental influences to vary across levels of environmental exposures, the researchers identified twelve small but statistically significant interaction effects. These involved age, smoking, alcohol consumption, education, and mental health status—factors that modulate how strongly genetic variants express themselves in measurable traits. In other words, the same set of genes may push blood pressure or blood sugar to different degrees depending on whether a person smokes, drinks, has reached a certain age, or carries psychological stress. The effect sizes were modest, but the pattern is consistent with the idea that genes and environment do not operate in separate silos; they collaborate, and that collaboration quietly shapes the heritability we observe.

The study also mapped the genetic correlations between pairs of cardiometabolic traits, asking whether the same genes influence more than one measure. The answers ranged from low to high, spanning 0.09 to 0.90, and—crucially—the patterns estimated from twin data broadly matched those derived from GWAS. This convergence matters. It suggests that the discrepancy between twin and GWAS heritability estimates does not reflect fundamentally different genetic pictures, but rather differences in what each method can detect. Twin models capture all inherited variation, including rare variants and effects in genomic regions poorly tagged by genotyping arrays, while GWAS-based estimates reflect only the additive effects of common SNPs that are well captured in the data.

There is also a broader significance to the population in which this work was conducted. The vast majority of large-scale genetic studies have been performed in populations of European ancestry, and researchers have warned repeatedly that findings from these studies do not always translate to other groups. Differences in allele frequencies, linkage disequilibrium patterns, and environmental contexts can all alter how genetic risk manifests. By grounding both the twin analyses and the GWAS heritability estimates in Asian populations, this study helps close a critical gap in the global picture of cardiometabolic genetics, providing evidence that the fundamental genetic architecture—high twin heritability, modest SNP heritability, minimal dominance, and pervasive gene-environment interplay—holds across ancestries.

Methodologically, the work is a showcase of integration. The twin component relied on classical structural equation modeling of monozygotic and dizygotic pairs, with zygosity confirmed through questionnaire-based assessment validated by methylation array data. The GWAS component drew on publicly available summary statistics from Asian cohorts, applying SNP-based heritability methods that estimate the variance explained by common variants through their correlations with the trait. By running both approaches on the same ten traits and comparing their outputs side by side, the team created a natural experiment in which each method could serve as a check and complement to the other.

For clinicians and public health researchers, the implications are tangible. The confirmation that BMI carries a substantial dominance component suggests that some obesity risk is inherited in ways that current additive polygenic models may underrepresent, potentially affecting the accuracy of genetic risk scores. The dozen identified gene-environment interactions point to modifiable levers—smoking cessation, alcohol moderation, mental health support, and attention to age-related changes—that could blunt genetic susceptibility. And the finding that genetic correlations between cardiometabolic traits are broadly consistent across methods strengthens confidence that pleiotropy, the phenomenon of one gene influencing multiple traits, is real and quantifiable. As the era of precision medicine accelerates, studies like this one provide the calibrated foundation on which genetic prediction, prevention, and treatment strategies must ultimately rest. The mystery of missing heritability is not solved in a single paper, but by systematically ruling out dominance effects, spotlighting gene-environment interactions, and demonstrating cross-method consistency in an understudied population, this work takes a substantial and welcome step toward that goal.

Subject of Research: Estimation of heritability and gene-environment interactions for cardiometabolic traits by integrating twin and GWAS data in Asian populations

Article Title: Revealing genetic foundations underlying cardiometabolic traits: integrating twin and GWAS data in Asian populations

Article References: Hong, X., Li, M., Cao, W., Lv, J., Yu, C., Huang, T., Sun, D., Liao, C., Pang, Y., Hu, R., Gao, R., Yu, M., Zhou, J., Wu, X., Liu, Y., Yin, S., Gao, W., & Li, L. (2026). Revealing genetic foundations underlying cardiometabolic traits: integrating twin and GWAS data in Asian populations. International Journal of Obesity. https://doi.org/10.1038/s41366-026-02209-w

Image Credits: AI Generated

DOI: 10.1038/s41366-026-02209-w

Keywords: heritability, twin study, GWAS, cardiometabolic traits, missing heritability, gene-environment interaction, BMI, blood pressure, lipids, genetic correlation, Chinese National Twin Registry, Asian populations